Clinical Trial Update: An Open-Label Trial Of Reduced- Dose Pylera, Amoxicillin, and Esomeprazole in the Treatment Of Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

A Phase 4 open-label trial of reduced-dose Pylera with amoxicillin and esomeprazole for Helicobacter pylori infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Esomeprazole (Esomeprazole)
• Pylera (bismuth subcitrate potassium; metronidazole; tetracycline)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Treatment of H. Pylori Infection | Phase 4 | Status: WITHDRAWN